CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

DexmethylphenidateWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug1000 Enhanced Chronic Disease Self-management program Wiki 1.00

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D002908 Chronic Disease NIH 0.29
D006973 Hypertension NIH 0.26

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0000822 Hypertension HPO 0.26

There is one clinical trial.

Clinical Trials

1 An Open-label, Randomized, Single-dose, Two-period, Two-treatment (Fed vs Fasted), Two-sequence, Crossover Study in Healthy Adult Subjects to Assess the Effect of Food on the Absorption and Bioavailability of CTx-1301 (Dexmethylphenidate)

The primary purpose of this study is to assess the effect of food on the rate and extent of absorption and the overall bioavailability of a single dose of CTx-1301 50 mg trimodal tablets in healthy adult volunteers.

NCT04449250 Healthy Volunteers in Fed and Fasted State Drug: Dexmethylphenidate

Primary Outcomes

Measure: Pharmacokinetic parameter (Cmax)

Time: Hour 0 to hour 28

Measure: Pharmacokinetic parameter (AUC0-inf)

Time: Hour 0 to hour 28

Measure: Pharmacokinetic parameter (AUC0-last)

Time: Hour 0 to hour 28

Secondary Outcomes

Measure: Pharmacokinetic parameter (AUC0-3)

Time: Hour 0 to hour 3

Measure: Pharmacokinetic parameter (AUC3-6)

Time: Hour 3 to hour 6

Measure: Pharmacokinetic parameter (AUC6-9)

Time: Hour 6 to hour 9

Measure: Pharmacokinetic parameter (AUC9-12)

Time: Hour 9 to hour 12

Measure: Pharmacokinetic parameter (AUC12-16)

Time: Hour 12 -16

Measure: Pharmacokinetic parameter K

Time: Hour 0 to hour 28

Measure: Pharmacokinetic parameter T1/2

Time: Hour 0 to hour 28

Measure: Pharmacokinetic parameter Tmax

Time: Hour 0 to hour 28

Measure: Pharmacokinetic parameter Tlag

Time: Hour 0 to hour 28

No related HPO nodes (Using clinical trials)